bufalin has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, K; Liang, X; Qiu, Y; Sun, M; Wang, Y; Wu, C; Xu, K; Yin, P; Yuan, Z; Zhan, Y; Zhu, R | 1 |
| Gao, F; Li, Y; Liu, C; Ma, S; Shang, J; Sun, Y; Wu, H; Yin, P; Yuan, Z; Zhan, Y | 1 |
| Feng, W; Hu, Q; Hu, SJ; Liang, B; Peng, W; Qiu, YY; Tang, QF; Yin, PH | 1 |
| Meng, Z; Ning, Z; Wang, H; Xu, L; Zhang, C; Zhu, X | 1 |
| Tang, D; Tao, X | 1 |
| Kuroiwa, Y; Lee, DY; Yamamoto, T; Yasuda, M; Yoshida, T | 1 |
1 review(s) available for bufalin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Advances in the study of tumor angiogenesis and anti-angiogenic Chinese herbal drugs].
Topics: Angiogenesis Inhibitors; Animals; Bufanolides; Drugs, Chinese Herbal; Ginsenosides; Glucans; Humans; Neoplasms; Neovascularization, Pathologic; Pentacyclic Triterpenes; Phytotherapy; Plants, Medicinal; Polysaccharides; Triterpenes | 2003 |
5 other study(ies) available for bufalin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway.
Topics: Angiogenesis Inhibitors; Animals; Bufanolides; Cell Movement; Cell Proliferation; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; STAT3 Transcription Factor; Tumor Microenvironment | 2021 |
Bufalin exacerbates Photodynamic therapy of colorectal cancer by targeting SRC-3/HIF-1α pathway.
Topics: Animals; Bufanolides; Cell Line, Tumor; Colorectal Neoplasms; Hypoxia; Mice; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents | 2022 |
MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Bufanolides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Humans; Male; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction | 2014 |
Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Bufanolides; Cell Cycle; Cell Movement; Cell Proliferation; Cell Survival; Chick Embryo; Cytokines; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Signal Transduction; Sorafenib; Vascular Endothelial Growth Factor A | 2016 |
Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro.
Topics: Animals; Bufanolides; Cattle; Cell Division; Cells, Cultured; Endothelium, Vascular; Flow Cytometry; G2 Phase; Microtubules; Mitosis; Neovascularization, Pathologic | 1997 |